Unc-51 Like Kinase 3 (ULK3) は,多発性骨髄腫における自己死と細胞生存に不可欠である
Marilena Tauro1, Tao Li1, Praneeth R Sudalagunta2
1Department of Tumor Microenvironment & Metastasis, H. Lee Moffitt Cancer Center and Research Institute; Tampa, FL, USA.
Research square
|August 20, 2025
まとめ
重要なオートファジー遺伝子であるULK3をターゲットにすることで,多発性骨髄腫 (MM) に対する新しい戦略が提供されます. ULK3を阻害すると,腫瘍の負荷が減り,耐性MM患者の薬剤感受性が回復する.
科学分野:
- 腫瘍学
- 分子生物学
- 細胞生物学
背景:
- 多発性骨髄腫 (MM) は,プロテアソーム阻害剤のような現在の治療法にもかかわらず,耐性疾患で再発することが多い.
- 新しい治療目標の特定は,MMの患者のアウトカムを改善するために不可欠です.
研究 の 目的:
- 多発性骨髄腫の進行における 自殺性遺伝子の役割を調査する.
- 潜在的治療標的としてULK3を評価する.
主な方法:
- 813人のCD138+MM患者サンプルによるRNA配列解析
- MM細胞生存におけるULK3の機能研究
- ULK3阻害剤 (SG3-014/MA9-060) の生成と試験
- マウスモデルでのin vivo試験と患者サンプルでのex vivo検証
主要な成果:
- オートファジー遺伝子シグネチャー,特にULK3発現とMM疾患の進行との強い関連が確認された.
- ULK3の抑制により,MM腫瘍の負荷が減り,生存率が改善され,骨疾患からインビボで保護された.
- ULK3阻害剤MA9 - 060は,耐性MM細胞におけるプロテアソーム阻害剤に対する感受性を回復させ,患者サンプルでシナジーが確認された.
結論:
- ULK3は,オートファジーによるMM細胞生存と疾患進行において重要な役割を果たします.
- ULK3抑制は,新たに診断された多発性骨髄腫と耐火性多発性骨髄腫の両方にとって有望な治療戦略です.
- ULK3抑制とプロテアソーム阻害剤の併用療法により,MMにおける薬剤耐性を克服する可能性がある.
関連する概念動画
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
PI3K/mTOR/AKT Signaling Pathway
3.9K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.9K
Autophagy
4.6K
Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
4.6K
Autophagic Cell Death
3.5K
Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
3.5K
The Intrinsic Apoptotic Pathway
6.8K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.8K


